-+ 0.00%
-+ 0.00%
-+ 0.00%

argenx to host autoimmune myositis R&D webinar on FcRn, efgartigimod program

PUBT·05/28/2026 05:00:45
Listen to the news
argenx to host autoimmune myositis R&D webinar on FcRn, efgartigimod program
  • argenx will host an “R&D Spotlight” webinar on autoimmune myositis on June 23, 2026 at 2:00 p.m. ET.
  • Discussion will cover the ALKIVIA clinical program design for efgartigimod in myositis, including clinical and commercial positioning.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. arGEN-X SE published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202605280100PRIMZONEFULLFEED1001184385) on May 28, 2026, and is solely responsible for the information contained therein.